1. Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine
   Gui-hua Lai et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
2. DLEU1: A Functional Long Noncoding RNA in Tumorigenesis
   Chaoying Song et al, 2020, Current Pharmaceutical Design CrossRef
3. NR2F1 Regulates TGF-β1-Mediated Epithelial-Mesenchymal Transition Affecting Platinum Sensitivity and Immune Response in Ovarian Cancer
   Qiuju Liang et al, 2022, Cancers CrossRef
4. Hypoxia-Related lncRNA Prognostic Model of Ovarian Cancer Based on Big Data Analysis
   Yu Zhang et al, 2023, Journal of Oncology CrossRef
5. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
   Chin-Jui Wu et al, 2019, Cancers CrossRef
6. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
   Gurcan Gunaydin, 2021, Frontiers in Oncology CrossRef
7. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
   Jacek R Wilczyński et al, 2022, International Journal of Molecular Sciences CrossRef
8. Exosomal miRNAs and lncRNAs: The Modulator Keys of Cancer-Associated Fibroblasts in the Genesis and Progression of Malignant Neoplasms
   Julio César Villegas-Pineda et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
9. Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
   Katarzyna Ratajczak-Wielgomas et al, 2020, International Journal of Molecular Sciences CrossRef
10. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer
    Fumiaki Takatsu et al, 2023, Journal of Molecular Medicine CrossRef
11. Tumor-Derived Extracellular Vesicles Activate Normal Human Fibroblasts to a Cancer-Associated Fibroblast-Like Phenotype, Sustaining a Pro-Tumorigenic Microenvironment
    Ilaria Giusti et al, 2022, Frontiers in Oncology CrossRef
12. Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
    Aleksandra Klemba et al, 2020, International Journal of Molecular Sciences CrossRef
13. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
    Jacek R. Wilczyński et al, 2023, Frontiers in Oncology CrossRef